Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Parodi

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Oncoimmunology|September 20, 2018
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptorSilvia Gaggero, Maurizio Bruschi, Andrea Petretto, et al.
Oncoimmunology|November 21, 2015
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitmentMonica Parodi, Marco Pedrazzi, Claudia Cantoni, et al.
Journal for Immunotherapy of Cancer|March 8, 2024
Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cellsMonica Parodi, Giovanni Centonze, Fabio Murianni, et al.
Cancers|October 27, 2022
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer TherapyMelania Grottoli, Paolo Carrega, Lodovica Zullo, et al.
Cancer Research|May 13, 2018
NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell LinesLeticía Huergo-Zapico, Monica Parodi, Claudia Cantoni, et al.
Journal for Immunotherapy of Cancer|February 12, 2025
CD56<sup>bright</sup> cytokine-induced memory-like NK cells and NK-cell engagers synergize against non-small cell lung cancer cancer-stem cellsMaria L Guevara Lopez, Ann Gebo, Monica Parodi, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Oncoimmunology|September 20, 2018
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptorSilvia Gaggero, Maurizio Bruschi, Andrea Petretto, et al.
Oncoimmunology|November 21, 2015
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitmentMonica Parodi, Marco Pedrazzi, Claudia Cantoni, et al.
Journal for Immunotherapy of Cancer|March 8, 2024
Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cellsMonica Parodi, Giovanni Centonze, Fabio Murianni, et al.
Cancers|October 27, 2022
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer TherapyMelania Grottoli, Paolo Carrega, Lodovica Zullo, et al.
Cancer Research|May 13, 2018
NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell LinesLeticía Huergo-Zapico, Monica Parodi, Claudia Cantoni, et al.
Journal for Immunotherapy of Cancer|February 12, 2025
CD56<sup>bright</sup> cytokine-induced memory-like NK cells and NK-cell engagers synergize against non-small cell lung cancer cancer-stem cellsMaria L Guevara Lopez, Ann Gebo, Monica Parodi, et al.
Pageof 3